The Alberta Government introduced a legislative proposal that allows doctors to work both publicly and privately. The idea behind this move is to trim the long waiting times for surgeries and other treatments in the public health system. The current health system could only do a little as it can’t afford extra operating time. Alberta […]
Alberta has been experiencing surging influenza cases since the last season, and experts say that this widespread is more fatal than before. The province reported the first influenza death case after several weeks of health caution alerts and follow-ups from health experts. As per Alberta’s Respiratory Virus Dashboard, the deceased person is a central zone […]
On Thursday, U.S. President Donald Trump unveiled a deal with Eli Lilly and Novo Nordisk, two American multinational pharmaceutical companies, to lower the prices of GLP-1 weight-loss drugs, making them more affordable for all consumers. This deal not only offers price cuts to drug treatments but also expands medical coverage. Patients covered by Medicare, a […]
Health Canada approves LEQEMBI (lecanemab), an antibody drug that can slow the cognitive decline in patients with early-stage Alzheimer’s disease. Eisai Ltd., a Japan-based pharmaceutical company, was the first to develop and manufacture the LEQEMBI drug, in joint partnership with Biogen, a US-based company and a major player in the biotechnology segment, and BioArctic, a […]
- Tags:
- Alzheimer’s care and support
- Alzheimer’s disease Canada
- Alzheimer’s drug approval
- Alzheimer’s medication Canada
- Alzheimer’s patient guide
- Alzheimer’s research news
- Alzheimer’s therapy access
- amyloid plaque
- APOE ε4
- ARIA monitoring
- brain health Canada
- dementia treatment update
- early Alzheimer’s treatment
- Eisai Biogen drug
- first disease-modifying therapy
- Health Canada approval
- Health Canada news release
- lecanemab
- LEQEMBI
- mild cognitive impairment
Simon Fraser University (SFU) clinical research study on cutting-edge advanced brain imaging technology to enhance epilepsy diagnosis and treatment in British Columbia is currently underway. What Reports Say? The BC Epilepsy Society report indicates that 50,000+ British Columbians are living with epilepsy. According to the WHO 2024 reports, 50 million people are suffering from epilepsy […]
- Tags:
- advanced brain imaging
- BC health innovation
- brain imaging
- British Columbia
- epilepsy care
- epilepsy research
- epilepsy treatment
- healthcare innovation
- medical breakthrough
- medical research
- MEG
- MRI
- neuroimaging
- neurological disorders
- neuroscience
- patient care
- precision medicine
- SFU
- SFU research
- Simon Fraser University
Alberta, a western Canadian province, has begun the second phase of vaccinations for influenza and COVID-19. Now you can get vaccinated by booking a shot online for around $100 on the Alberta Vaccine Booking System. This is the first time the Alberta government has put a price on the vaccine; however, the shot is free […]
Are you using VESTA’s VRP or VRS Tankless Water Heater at home? If yes, stop using it right now. Here’s why. Recently, VRS, VRS Plus, VRP, and VRP Plus models were recalled due to cracked exhaust ducts. Till October 10, 2025, VESTA has received 10 reports of cracked exhaust ducts across Canada and 33 reports […]
Say adios to long travel for MRI services, as Collingwood General and Marine Hospital (CGMH) launched its first MRI machine program, bringing ease of diagnostic access closer to home. The MRI establishment spans across 2000 square feet of the newly renovated hospital space. This new initiative not only provides swift and homely services to the […]
University of Calgary Scientists are collecting toenail samples for a lung cancer study. Dr. Aaron Goodarzi, a PhD researcher & professor at the University of Calgary, is leading this study from the forefront. Emi Bossio, a 47-year-old woman who had a prosperous law practice and a stable, healthy life, raising two thriving children, found herself […]
On October 9, 2025, Interior Health announced the appointment of Sylvia Weir as the new President and CEO. She acted as an interim (President and CEO) since Susan Brown’s exit in June 2025. Previously, Sylvia held a top position in the company as the Chief Financial Officer (CFO), handling and managing all the business financials. […]